The combi-targeting concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)/DNA targeting “combi-triazene” SMA41-Reference-Cited by-同舟云学术

The combi-targeting concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)/DNA targeting “combi-triazene” SMA41

Published:2004-03 Issue:6 Volume:67 Page:1131-1138
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Matheson Stephanie L,Brahimi Fouad,Jean-Claude Bertrand J

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference19 articles.

1. Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest by deprivation of epidermal growth factor;Chou;Breast Cancer Res. Treat,1999

2. Epidermal growth factor receptor activation in androgen-independent but not androgen-dependent growth of human prostate carcinoma cells;Sherwood;Br. J. Cancer,1999

3. Activated extracellular signal-related kinases: association with epidermal growth factor receptor/transforming growth factor-α expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments;Albanell;Cancer Res.,2001

4. New therapeutic agents targeting the epidermal growth factor receptor;Baselga;J. Clin. Oncol.,2000

5. Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types;Baselga;J. Clin. Oncol.,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model;Cells;2023-03-16

2. Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy;Journal of Medicinal Chemistry;2022-03-21

3. Subcellular distribution and mechanism of action of AL906, a novel and potent EGFR inhibitor rationally designed to be green fluorescent;Investigational New Drugs;2020-07-09

4. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules;Current Pharmaceutical Design;2019-08-16

5. 15N-, 13C- and 1H-NMR Spectroscopy Characterization and Growth Inhibitory Potency of a Combi-Molecule Synthesized by Acetylation of an Unstable Monoalkyltriazene;Molecules;2017-07-19